GPP
MGNX icon

Great Point Partners’s MacroGenics MGNX Stock Holding History

Great Point Partners’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000,000
Closed -$16.1M – 35
2021
Q4 		$16.1M Hold
1,000,000
– – 3.57% 10
2021
Q3 		$20.9M Sell
1,000,000
-378,495
-27% -$9.12M 4.88% 6
2021
Q2 		$37M Buy
1,378,495
+28,495
+2% +$834K 7.77% 1
2021
Q1 		$43M Buy
1,350,000
+110,713
+9% +$2.69M 8.89% 1
2020
Q4 		$28.3M Sell
1,239,287
-270,928
-18% -$6.24M 4.6% 9
2020
Q3 		$38M Buy
1,510,215
+10,215
+0.7% +$279K 3.42% 11
2020
Q2 		$41.9M Buy
+1,500,000
New +$26.1M 3.35% 12

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Great Point Partners's MGNX Position: Q1 2022 in Review

Great Point Partners sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 1,000,000 shares — an estimated $16.1M sold.

Great Point Partners first reported a position in MGNX in Q2 2020 and held it in 7 quarters. The position peaked at $43M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Great Point Partners reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • Great Point Partners sold 1,000,000 MacroGenics shares in Q1 2022, an estimated $16.1M.
  • Great Point Partners first reported a position in MacroGenics in Q2 2020 and held it in 7 quarters.
  • Great Point Partners's MacroGenics position peaked at $43M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Great Point Partners's 13F filing for Q1 2022, filed 16 May 2022.